Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Unlabelled Application of the WHO fracture prediction algorithm in conjunction with an updated US economic analysis indicates that osteoporosis treatment is cost-effective in patients with fragility fractures or osteoporosis, in older individuals at average risk and in younger persons with additional clinical risk factors for fracture, supporting existing practice recommendations. Introduction The new WHO fracture prediction algorithm was combined with an updated economic analysis to evaluate existing NOF guidance for osteoporosis prevention and treatment. Methods The WHO fracture prediction algorithm was calibrated to the US population using national age-, sex- and race-specific death rates and age- and sex-specific hip fracture incidence rates from the largely white population of Olmsted County, MN. Fracture incidence for other races was estimated by ratios to white women and men. The WHO algorithm estimated the probability (%) of a hip fracture (or a major osteoporotic fracture) over 10 years, given specific age, gender, race and clinical profiles. The updated economic model suggested that osteoporosis treatment was cost-effective when the 10-year probability of hip fracture reached 3%. Results It is cost-effective to treat patients with a fragility fracture and those with osteoporosis by WHO criteria, as well as older individuals at average risk and osteopenic patients with additional risk factors. However, the estimated 10-year fracture probability was lower in men and n…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The latter analyses generally confirm the previous NOF conclusion that it is cost-effective to treat individuals with a prior hip or vertebral fracture and those with a DXA femoral neck T-score ≤−2.5.”
From Clinician’s Guide to Prevention and Treatment of Osteoporosis (2014) · cites this paper as [13]
In the citing paper
“The latter analyses generally confirm the previous NOF conclusion that it is cost-effective to treat individuals with a prior hip or vertebral fracture and those with a DXA femoral neck T-score ≤−2.5.”
From Clinician’s Guide to Prevention and Treatment of Osteoporosis (2014) · cites this paper as [13]
In the citing paper
“Therapeutic intervention thresholds are based on NOF’s economic analysis that takes into consideration the cost-effectiveness of treatments and competition for resources in the USA [12, 13].”
From Clinician’s Guide to Prevention and Treatment of Osteoporosis (2014) · cites this paper as [13]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889 · cited 2×
“Questions have been raised about the utility of estrogen therapy [6, 7], the mainstay of earlier treatment recommendations for postmenopausal women [5], and new drugs have been introduced [8].”
BackgroundPrevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190 · cited 1×
“Since BMI is strongly correlated with femoral neck BMD, and is less useful for fracture risk prediction when hip BMD is available [33], analyses were adjusted to the upper limit of “healthy” weight, a BMI of 24.9 [ 34 ].”
Influential(2004) · JAMA · doi:10.1001/jama.291.14.1701 · Cited by 4,534 · cited 2×
“Questions have been raised about the utility of estrogen therapy [6, 7], the mainstay of earlier treatment recommendations for postmenopausal women [5], and new drugs have been introduced [8].”
BackgroundIncidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
Burge, R., Dawson-Hughes, B., Solomon, D. H., Wong, J. B., King, A., & Tosteson, A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061113 · Cited by 4,026 · cited 5×
“Thresholds for evaluating the cost-effectiveness of treatment have been revised [11], and of course, costs have also increased [10].”
BackgroundMethodInfluentialSelf-citationProfessor Kanis, J. A., Melton, L. J., Christiansen, C., Johnston, C. C., & Khaltaev, N. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090802 · Cited by 3,849
Self-citationEpidemiology and outcomes of osteoporotic fractures
Cummings, S. R., & Melton, L. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08657-9 · Cited by 3,821 · cited 2×
“This is partly due to the fact that average hip fracture risk in these groups is substantially less than that in white women [32].”
BackgroundResultSelf-citationFRAX™ and the assessment of fracture probability in men and women from the UK
Kanis, J. A., Johnell, O., Oden, A., Johansson, H., & McCloskey, E. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0543-5 · Cited by 2,467 · cited 4×
“As described elsewhere [12], the risk factors include age, femoral neck BMD (T-score or Z-score compared to norms from the National Health and Nutrition Examination Survey [18]) and body mass index (BMI) as continuous variables, along with a personal history of prior fragility fracture, rheumatoid arthritis, other put…”
BackgroundMethodInfluentialCummings, S. R. (1998) · JAMA · doi:10.1001/jama.280.24.2077 · Cited by 2,277 · cited 1×
“the costs and complications of therapy, even presuming that treatment would be efficacious in osteopenic women generally [46].”
BackgroundDiagnosis of osteoporosis and assessment of fracture risk
Kanis, J. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08761-5 · Cited by 2,260 · cited 1×
“Thus, the 10-year fracture probability in an average-risk 50-year-old white woman is quite low [60], suggesting that treatment of such patients will not be costeffective [13, 61].”
BackgroundBlack, D. M., & Rosen, C. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1513724 · Cited by 1,712
A meta-analysis of previous fracture and subsequent fracture risk
Kanis, J. A., Johnell, O., De Laet, C., Johansson, H., Oden, A., Delmas, P., Eisman, J., Fujiwara, S., Garnero, P., Kroger, H., et al. (2004) · Bone · doi:10.1016/j.bone.2004.03.024 · Cited by 1,278 · cited 2×
“The combined cohort comprised over 60,000 subjects, who were followed for a quarter of a million person-years; 5,563 fractures were observed during followup, including 978 hip fractures [3].”
BackgroundSelf-citationKanis, J. A., Borgstrom, F., De Laet, C., Johansson, H., Johnell, O., Jonsson, B., Oden, A., Zethraeus, N., Pfleger, B., & Khaltaev, N. (2005) · Osteoporosis International · doi:10.1007/s00198-004-1780-5 · Cited by 1,233
Kanis, J. A., Oden, A., Johnell, O., Johansson, H., De Laet, C., Brown, J., Burckhardt, P., Cooper, C., Christiansen, C., Cummings, S., et al. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0343-y · Cited by 1,224 · cited 1×
“The model has been validated in 11 additional study cohorts that were not used in building the fracture prediction algorithm [19].”
MethodSelf-citationUpdated Data on Proximal Femur Bone Mineral Levels of US Adults
Looker, A. C., Wahner, H. W., Dunn, W. L., Calvo, M. S., Harris, T. B., Heyse, S. P., Johnston Jr, C. C., & Lindsay, R. (1998) · Osteoporosis International · doi:10.1007/s001980050093 · Cited by 1,121 · cited 2×
“As described elsewhere [12], the risk factors include age, femoral neck BMD (T-score or Z-score compared to norms from the National Health and Nutrition Examination Survey [18]) and body mass index (BMI) as continuous variables, along with a personal history of prior fragility fracture, rheumatoid arthritis, other put…”
Self-citationBone Mineral Density Thresholds for Pharmacological Intervention to Prevent Fractures
Siris, E. S., Chen, Y.-T., Abbott, T. A., Barrett-Connor, E., Miller, P. D., Wehren, L. E., & Berger, M. L. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.10.1108 · Cited by 1,093
Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
American College of Rheumatology task force on Osteoporosis guidelines (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391104 · Cited by 848
A meta-analysis of prior corticosteroid use and fracture risk.
Kanis, J. A., Johansson, H., Oden, A., Johnell, O., de Laet, C., Melton, L. J., Tenenhouse, A., Reeve, J., Silman, A. J., Pols, H. A., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040134 · Cited by 839 · cited 1×
“In particular, use of systemic corticosteroids is associated with excessive bone loss and fracture risk [49], and the American College of Rheumatology has recommended that patients beginning treatment with ≥ 5 mg/d of prednisone equivalent glucocorticoids for 3 months or more, along with patients already on such doses…”
BackgroundSelf-citationMean body weight, height, and body mass index, United States 1960-2002.
Ogden, C. L., Fryar, C. D., Carroll, M. D., & Flegal, K. M. (2004) · PubMed · Cited by 717
Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update
American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1496::aid-art271>3.0.co;2-5 · Cited by 647
Osteoporosis and Fracture Risk in Women of Different Ethnic Groups
Barrett-Connor, E., Siris, E. S., Wehren, L. E., Miller, P. D., Abbott, T. A., Berger, M. L., Santora, A. C., & Sherwood, L. M. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041007 · Cited by 557 · cited 1×
“In the NORA study, osteoporotic fracture rates in postmenopausal Hispanic, African-American and Asian women were only 91%, 54% and 41%, respectively, of those in white women even after adjusting for age, peripheral BMD and some of the risk factors included in the WHO algorithm [55].”
BackgroundBasic Epidemiology of Fractures of the Upper and Lower Limb among Americans over 65 Years of Age
Baron, J. A., Karagas, M., Barrett, J., Kniffin, W., Malenka, D., Mayor, M., & Keller, R. B. (1996) · Epidemiology · doi:10.1097/00001648-199611000-00008 · Cited by 463 · cited 1×
“53 for men [23–29]; for Hispanics, 0.”
Cost-effective osteoporosis treatment thresholds: the United States perspective
Tosteson, A. N. A., Melton, L. J., Dawson-Hughes, B., Baim, S., Favus, M. J., Khosla, S., & Lindsay, R. L. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0550-6 · Cited by 441 · cited 8×
“The updated NOF economic analysis estimated drug costs at $600 per year in anticipation of generic bisphosphonate [13]; however, if the drug cost were further reduced from $600 to $300, then the level of 10-year hip fracture risk that is cost-effective to treat falls to 1.”
BackgroundMethodInfluentialSelf-citationElliot-Gibson, V., Bogoch, E. R., Jamal, S. A., & Beaton, D. E. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1675-5 · Cited by 426 · cited 1×
“Conversely, only a minority of the high risk patients who present with a fracture are treated to reduce the risk of additional fractures in the future [62].”
BackgroundMelton III, L. J., Crowson, C. S., & O'Fallon, W. M. (1999) · Osteoporosis International · doi:10.1007/s001980050113 · Cited by 385 · cited 5×
“Although incidence rates for hip fractures recently became available from the Nationwide Inpatient Sample, a large US hospital discharge database [10], the model had already been calibrated to population-based data from the largely white community of Olmsted County, MN [21].”
MethodResultInfluentialSelf-citationThe population burden of fractures originates in women with osteopenia, not osteoporosis
Pasco, J. A., Seeman, E., Henry, M. J., Merriman, E. N., Nicholson, G. C., & Kotowicz, M. A. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0135-9 · Cited by 362 · cited 1×
“This is an important issue since postmenopausal women with osteopenia but not osteoporosis accounted for half of the fractures observed in the large National Osteoporosis Risk Assessment (NORA) study [43], and similar results have been reported by others [44, 45].”
ResultScreening for Osteoporosis in Postmenopausal Women: Recommendations and Rationale
U.S. Preventive Services Task Force* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-6-200209170-00014 · Cited by 344 · cited 2×
“This conclusion is supported by another recent cost-effectiveness analysis using US data [48] and has been endorsed by the US Preventive Services Task Force [4].”
MethodA New Approach to the Development of Assessment Guidelines for Osteoporosis
Kanis, J. A., Black, D., Cooper, C., Dargent, P., Dawson-Hughes, B., De Laet, C., Delmas, P., Eisman, J., Johnell, O., Jonsson, B., et al. (2002) · Osteoporosis International · doi:10.1007/s001980200069 · Cited by 338 · cited 1×
“, [36–38]), recommend osteoporosis evaluation and consideration of treatment for patients who present with frank osteoporosis and/or a personal history of fragility fracture.”
BackgroundSelf-citationArias, E., Anderson, R. N., Kung, H.-C., Murphy, S. L., & Kochanek, K. D. (2003) · PubMed · Cited by 313
Bone Mineral Density and the Risk of Incident Nonspinal Fractures in Black and White Women
Cauley, J. A. (2005) · JAMA · doi:10.1001/jama.293.17.2102 · Cited by 274 · cited 1×
“Others have made similar findings [56].”
Epidemiology of Diaphyseal and Distal Femoral Fractures in Rochester, Minnesota, 1965-1984
ARNESON, T. J., MELTON, L. J., LEWALLEN, D. G., & O'FALLON, W. M. (1988) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198809000-00033 · Cited by 262 · cited 1×
“The discrepancy is partly due to the fact that subtrochanteric fractures, which account for approximately 5% of all proximal femur fractures [22], are excluded from the Olmsted County data.”
BackgroundSelf-citationRosen, C. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp043801 · Cited by 256 · cited 1×
“Questions have been raised about the utility of estrogen therapy [6, 7], the mainstay of earlier treatment recommendations for postmenopausal women [5], and new drugs have been introduced [8].”
BackgroundSilverman, S. L., & Madison, R. E. (1988) · American Journal of Public Health · doi:10.2105/ajph.78.11.1482 · Cited by 252 · cited 1×
“58 for men [23, 24, 29, 30]; and for those of Asian ancestry, 0.”
BackgroundHip fracture incidence among the old and very old: a population-based study of 745,435 cases.
Jacobsen, S. J., Goldberg, J., Miles, T. P., Brody, J. A., Stiers, W., & Rimm, A. A. (1990) · American Journal of Public Health · doi:10.2105/ajph.80.7.871 · Cited by 220 · cited 1×
“53 for men [23–29]; for Hispanics, 0.”
RACIAL DIFFERENCES IN FRACTURE RISK
Baron, J. A., Barrett, J., Malenka, D., Fisher, E., Kniffin, W., Bubolz, T., & Tosteson, T. (1994) · Epidemiology · doi:10.1097/00001648-199401000-00008 · Cited by 198 · cited 1×
“53 for men [23–29]; for Hispanics, 0.”
Sanders, K. M., Nicholson, G. C., Watts, J. J., Pasco, J. A., Henry, M. J., Kotowicz, M. A., & Seeman, E. (2006) · Bone · doi:10.1016/j.bone.2005.06.004 · Cited by 187 · cited 1×
“This is an important issue since postmenopausal women with osteopenia but not osteoporosis accounted for half of the fractures observed in the large National Osteoporosis Risk Assessment (NORA) study [43], and similar results have been reported by others [44, 45].”
ResultLifetime Risk of Hip Fractures is Underestimated
Oden, A., Dawson, A., Dere, W., Johnell, O., Jonsson, B., & Kanis, J. A. (1998) · Osteoporosis International · doi:10.1007/s001980050105 · Cited by 169 · cited 1×
“Using these interrelationships, researchers have estimated that the probability of a hip fracture (or a major osteoporotic fracture encompassing hip fractures, clinically evident vertebral fractures, proximal humerus and distal forearm fractures) for various combinations of risk factors in a Poisson regression model w…”
BackgroundHip Fracture Incidence among Elderly Asian-American Populations
Lauderdale, D. S., Jacobsen, S. J., Furner, S. E., Levy, P. S., Brody, J. A., & Goldberg, J. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009304 · Cited by 168 · cited 1×
“The model was further calibrated to different ethnic populations by assuming a ratio of incidence rates for each group relative to hip fracture incidence among white women and men, but the optimal ratios are uncertain since hip fracture incidence can vary even among subpopulations of a given race [31] or ethnicity [30…”
MethodMagnitude and Impact of Osteoporosis and Fractures
Melton, L. J., & Cooper, C. (2001) · Osteoporosis · doi:10.1016/b978-012470862-4/50022-2 · Cited by 168
Self-citationFalls in African American and White Community-Dwelling Elderly Residents
Hanlon, J. T., Landerman, L. R., Fillenbaum, G. G., & Studenski, S. A. (2002) · The Journals of Gerontology Series A · doi:10.1093/gerona/57.7.m473 · Cited by 142 · cited 1×
“By contrast, race was not an independent predictor of falling when other factors were accounted for in a separate study [57].”
BackgroundLaet, C. E. D. H. D., Odén, A., Johansson, H., Johnell, O., Jönsson, B., & Kanis, J. А. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1689-z · Cited by 141 · cited 1×
“A more effective alternative is to improve the gradient-of-risk of the screening instrument by combining the BMD test result with clinical risk factors [47].”
BackgroundBorgström, F., Johnell, O., Kanis, J. A., Jönsson, B., & Rehnberg, C. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0107-0 · Cited by 138 · cited 1×
“Thresholds for evaluating the cost-effectiveness of treatment have been revised [11], and of course, costs have also increased [10].”
BackgroundKhosla, S., & Melton, L. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp070341 · Cited by 136
Self-citationCost-Effectiveness of Alendronate Therapy for Osteopenic Postmenopausal Women
Schousboe, J. T., Nyman, J. A., Kane, R. L., & Ensrud, K. E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-9-200505030-00008 · Cited by 131 · cited 1×
“Thus, the 10-year fracture probability in an average-risk 50-year-old white woman is quite low [60], suggesting that treatment of such patients will not be costeffective [13, 61].”
BackgroundIntervention thresholds for osteoporosis in the UK
Kanis, J. А., Borgström, F., Zethraeus, N., Johnell, O., Odén, A., & Jönsson, B. (2004) · Bone · doi:10.1016/j.bone.2004.08.018 · Cited by 129 · cited 1×
“Costeffectiveness analyses support that policy [5, 39, 40].”
ETHNIC DIFFERENCES IN HIP FRACTURE: A REDUCED INCIDENCE IN MEXICAN AMERICANS1
Bauer, R. L. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114774 · Cited by 120 · cited 1×
“58 for men [23, 24, 29, 30]; and for those of Asian ancestry, 0.”
BackgroundBlack-White Differences in Fracture Rates
Griffin, M. R., Ray, W. A., Fought, R. L., & Melton, L. J. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116450 · Cited by 117 · cited 1×
“53 for men [23–29]; for Hispanics, 0.”
Self-citationNational Trends in Osteoporosis Visits and Osteoporosis Treatment, 1988-2003
Stafford, R. S., Drieling, R. L., & Hersh, A. L. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.14.1525 · Cited by 116 · cited 1×
“Indeed, data from a representative sample of office-based physicians in the USA revealed a 10-fold increase between 1994 and 2003 in the number of osteoporosis patients identified and treated [59].”
BackgroundIncreasing hip fracture incidence in California Hispanics, 1983 to 2000
Zingmond, D. S., Melton, L. J., & Silverman, S. L. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1592-7 · Cited by 115 · cited 1×
“58 for men [23, 24, 29, 30]; and for those of Asian ancestry, 0.”
BackgroundSelf-citationIntervention thresholds for osteoporosis in men and women: a study based on data from Sweden
Kanis, J. А., Johnell, O., Odén, A., Borgström, F., Johansson, H., Laet, C. E. D. H. D., & Jönsson, B. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1623-4 · Cited by 113 · cited 1×
“Costeffectiveness analyses support that policy [5, 39, 40].”
Schousboe, J. T., Ensrud, K. E., Nyman, J. A., Melton, L. J., & Kane, R. L. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53504.x · Cited by 104 · cited 1×
“This conclusion is supported by another recent cost-effectiveness analysis using US data [48] and has been endorsed by the US Preventive Services Task Force [4].”
MethodSelf-citationDelmas, P. D., RIZZOLI, R. E., Cooper, C. C., & Reginster, J. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1813-0 · Cited by 89
Hip fracture incidence among elderly Hispanics.
Lauderdale, D. S., Jacobsen, S. J., Furner, S. E., Levy, P. S., Brody, J. A., & Goldberg, J. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.8.1245 · Cited by 59 · cited 2×
“58 for men [23, 24, 29, 30]; and for those of Asian ancestry, 0.”
BackgroundMethodVariations in Bone Density among Persons of African Heritage
Melton, L. J., Marquez, M. A., Achenbach, S. J., Tefferi, A., O’Connor, M. K., O’Fallon, W. M., & Riggs, B. L. (2002) · Osteoporosis International · doi:10.1007/s001980200072 · Cited by 59 · cited 1×
“That said, data on the determinants of fracture risk in men and non-white women remain limited, and it is not certain whether their lower fracture incidence rates are an inherent characteristic of ethnicity or are due instead to a different distribution of known risk factors such as bone size or likelihood of falling…”
BackgroundSelf-citationReview of guidelines for bone mineral density testing and treatment of osteoporosis
Lewiecki, E. M. (2005) · Current Osteoporosis Reports · doi:10.1007/s11914-005-0014-x · Cited by 47 · cited 1×
“, [36–38]), recommend osteoporosis evaluation and consideration of treatment for patients who present with frank osteoporosis and/or a personal history of fragility fracture.”
BackgroundEttinger, B. B., Hillier, T. A., Pressman, A. R., Che, M., & Hanley, D. A. (2005) · Journal of Women s Health · doi:10.1089/jwh.2005.14.159 · Cited by 41 · cited 1×
“Although the estimated fracture probabilities themselves are not necessarily precise [63], this is certainly a better way to communicate fracture risk than trying to explain the fracture implications of the BMD T-score, and it should facilitate better decisionmaking [64].”
BackgroundA 55-Year-Old Woman With Osteopenia
Cummings, S. R. (2006) · JAMA · doi:10.1001/jama.296.21.2601 · Cited by 39 · cited 1×
“There is less agreement about what to do for patients with low bone mass, or osteopenia [41, 42].”
BackgroundFarley, J. F., Cline, R. R., & Gupta, K. (2005) · Osteoporosis International · doi:10.1007/s00198-005-2027-9 · Cited by 25 · cited 1×
“The inclusion of men and different ethnicities in this analysis is an important advance because osteoporotic fractures are increasing in these groups [10], yet osteoporosis screening and intervention have been largely neglected [52, 53].”
BackgroundOsteoporotic fragility fractures in African Americans: under-recognized and undertreated.
Alam, N. M., Archer, J. A., & Lee, E. (2004) · PubMed Central · Cited by 24
Seniors' preferences for cancer screening and medication use based on absolute risk reduction.
Murphy, D., Gahm, G., Santilli, S., North, P., Oliver, S., & Shapiro, H. (2002) · The journals of gerontology. Series A, Biological sciences and medical sciences · doi:10.1093/gerona/57.2.m100 · Cited by 16 · cited 1×
“Compared to BMD T-scores, the use of absolute fracture risk estimates may provide a better basis for shared decision making between patient and physician [14] but may also dictate changes in current management recommendations [15].”
BackgroundVOSS, K. (2009) · Elsevier eBooks · doi:10.1016/b978-0-7020-2986-8.00011-2 · Cited by 15
Predicting fracture risk: Tougher than it looks
Browner, W. S. (2007) · BoneKEy-Osteovision · doi:10.1138/20070269 · Cited by 11 · cited 1×
“Although the estimated fracture probabilities themselves are not necessarily precise [63], this is certainly a better way to communicate fracture risk than trying to explain the fracture implications of the BMD T-score, and it should facilitate better decisionmaking [64].”
BackgroundLeslie, W. D., Siminoski, K. G., & Brown, J. P. (2007) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2007.01.003 · Cited by 10 · cited 1×
“Compared to BMD T-scores, the use of absolute fracture risk estimates may provide a better basis for shared decision making between patient and physician [14] but may also dictate changes in current management recommendations [15].”
Background
Research works printed but not linked: 1
- U.S.D.H.H.S. (2004) Chapter 4. The Frequency of Bone Disease. Bone Health and Osteoporosis: A Report of the Surgeon General. U.S. Department of Health and Human Services, Rockville, MD, pp 69–87
Cited by
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149
Self-citationEuropean guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., McCloskey, E. V., Johansson, H., Cooper, C., Rizzoli, R., Reginster, J.-Y., & on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) · Osteoporosis International · doi:10.1007/s00198-012-2074-y · Cited by 2,948
The clinician's guide to prevention and treatment of osteoporosis
LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., & Siris, E. S. (2022) · Osteoporosis International · doi:10.1007/s00198-021-05900-y · Cited by 1,487
Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., et al. (2020) · Endocrine Practice · doi:10.4158/gl-2020-0524suppl · Cited by 1,182
“Decision-Making on Pharmacologic Therapy Therapeutic intervention thresholds vary from country to country based on the cost of treatments, the approach taken to setting the intervention threshold, and available therapeutic modalities and resources (206,209).”
Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.esgl · Cited by 1,140
Metadata
- Authors
- Dawson-Hughes, B., Tosteson, A. N. A., Melton, L. J., Baim, S., Favus, M. J., Khosla, S., & Lindsay, R. L.
- Affiliations
- Dartmouth Institute for Health Policy and Clinical Practice (US)
- Mayo Clinic (US)
- Medical College of Wisconsin (US)
- University of Chicago (US)
- Helen Hayes Hospital (US)
- Venue
- Osteoporosis International
- Published
- 2008-02-22
- Volume
- 19
- Issue
- 4
- Pages
- 449-458
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- OpenAlex
- W2059857909
- Cited by
- 427
- References
- 63
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 12 · 2022: 15 · 2021: 9 · 2020: 22 · 2019: 12 · 2018: 10 · 2017: 15 · 2016: 18 · 2015: 23 · 2014: 22 · 2013: 31 · 2012: 32
- FWCI
- 60.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Osteoporosis International (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG012262)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Surgery › Hip and Femur Fractures
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- osteoporosis, fracture risk assessment, cost-effectiveness, osteoporosis treatment, hip fracture, fragility fractures, osteoporosis prevention, shared decision-making, Olmsted County, Minnesota
- MeSH terms
- Aged, Aged, 80 and over, Algorithms, Cost-Benefit Analysis, Female, Hip Fractures, Humans, Male, Middle Aged, Osteoporosis, Probability, United States, Bone Density, Spinal Fractures, Practice Guidelines as Topic, Age Distribution, Risk Assessment, Fractures, Bone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.